Pharmacologic management during therapeutic hypothermia

Kyle A Weant1, Stephanie N Baker

  • 1Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, USA.

Insights

Therapeutic hypothermia shows promise in improving survival and neurological outcomes for out-of-hospital cardiac arrest patients. This therapy involves controlled cooling and rewarming, with specific pharmacologic management to minimize complications and enhance patient recovery.

Area of Science:

  • Emergency Medicine
  • Cardiology
  • Neurology

Background:

  • Out-of-hospital cardiac arrest (OHCA) has a high mortality rate, often exceeding 90%.
  • Survivors of OHCA frequently experience significant neurological deficits, with over 50% suffering brain damage.
  • Limited therapeutic options exist to improve outcomes for OHCA patients.

Purpose of the Study:

  • To evaluate the effectiveness of therapeutic hypothermia in improving outcomes for OHCA survivors.
  • To review the physiological effects and management strategies associated with therapeutic hypothermia.

Main Methods:

  • Analysis of two landmark randomized controlled trials on therapeutic hypothermia post-OHCA.
  • Examination of the physiological processes during cooling and rewarming phases.
  • Review of pharmacologic interventions to support hypothermia therapy.

Main Results:

  • Therapeutic hypothermia demonstrated significant improvements in both neurological outcomes and mortality rates in OHCA patients.
  • Established protocols for cooling, rewarming, and pharmacologic management are crucial for efficacy.

Conclusions:

  • Therapeutic hypothermia is a vital intervention for improving survival and neurological function after out-of-hospital cardiac arrest.
  • Healthcare providers require comprehensive knowledge of hypothermia protocols, physiological responses, and pharmacologic adjuncts for optimal patient care.

Related Concept Videos

Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Thermoregulation01:26

Thermoregulation

The human body has a sophisticated thermoregulation system that employs negative feedback mechanisms to maintain an optimal core temperature. When the core temperature drops, peripheral and central thermoreceptors send signals to the hypothalamus, activating the heat-promoting center. This center triggers several responses aimed at increasing the core temperature. First, vasoconstriction reduces the flow of warm blood from internal organs to the skin so that the heat is not lost from the skin,...